Early lung cancer screening (LCS) through low-dose computed tomography (LDCT) is crucial but underused due to various barriers, including incomplete or inaccurate patient smoking data in the electronic health record and limited time for shared decision-making. The objective of this trial is to investigate a patient-centered intervention, MyLungHealth, delivered through the patient portal. The intervention is designed to improve LCS rates through increased identification of eligible patients and informed decision making.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Study 1 Primary Outcome: Count of Patients Newly Identified as Eligible for Lung Cancer Screening
Timeframe: 1 year trial period
Study 2 Primary Outcome: Count of Participants for Whom LDCT Was Ordered.
Timeframe: 1 year trial period